Neoadjuvant immunotherapy versus chemoimmunotherapy in non-small cell lung cancer: A protocol for systematic review and meta-analysis.
Qunying ZhuGuini ChenYunzhong LiuYu ZhouPublished in: Medicine (2023)
This evidence will be useful to practitioners, patients, and health policy-makers regarding the use of neoadjuvant chemoimmunotherapy in NSCLC.
Keyphrases
- rectal cancer
- public health
- healthcare
- end stage renal disease
- lymph node
- locally advanced
- newly diagnosed
- ejection fraction
- mental health
- chronic kidney disease
- primary care
- randomized controlled trial
- prognostic factors
- squamous cell carcinoma
- radiation therapy
- health information
- climate change
- social media
- human health